APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2)

Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units. The lattice is an all-sp³, rigid three-dimensional network whose local connectivity echoes that of diamond, conferring exceptional chemical inertness, thermal robustness, and pronounced hydrophobicity. In structural hierarchy, diamantane is the higher homologue of adamantane, preserving the same symmetry logic while increasing framework complexity.

Adamantane (C₁₀H₁₆) is a colorless crystalline solid with a camphor-like odor and is the prototypical diamondoid. Its defining feature is a strain-free, highly symmetrical tricyclic cage of saturated, tetrahedral carbons that restricts internal bond rotation relative to ordinary acyclic or monocyclic hydrocarbons. Adamantane occurs naturally in certain crude oils and is also readily accessible synthetically, making it a durable scaffold for structure–property studies and a useful building block in materials and molecular design.

Synthetically, adamantane can be produced via the thermal, catalyst-assisted rearrangement of dicyclopentadiene (C₁₀H₁₆ → C₁₀H₁₆, Δ, catalyst), a classic cage-forming transformation that delivers a low-strain, high-symmetry framework from readily available feedstock. This blueprint underpins routes to higher diamondoids such as diamantane by extending the logic of cage construction from simpler polycyclic precursors.

According to APO Research’s survey and statistical analysis, the global diamantane market was valued at US$442.21 thousand in 2023 and is projected to reach US$697.62 thousand by 2030, implying a 2024–2030 CAGR of 6.83%. The global adamantane market was valued at US$184.47 million in 2023 and is expected to reach US$262.53 million by 2030 (CAGR 4.97%). By production value, North America’s adamantane market rises from US$51.84 million (2023) to US$72.62 million (2030; 4.75%), while diamantane increases from US$217.62 thousand to US$354.61 thousand (7.49%). Europe’s adamantane advances from US$28.91 million to US$39.80 million (4.44%) and diamantane from US$51.38 thousand to US$76.60 thousand (5.27%). China’s adamantane expands from US$44.45 million to US$71.04 million (6.66%) and diamantane from US$70.22 thousand to US$114.88 thousand (7.51%). Japan’s adamantane grows from US$40.73 million to US$55.47 million (4.28%) and diamantane from US$99.85 thousand to US$147.20 thousand (5.79%). Overall, adamantane retains the larger revenue base with steady growth, while diamantane—though smaller in absolute terms—exhibits a faster compound growth trajectory over 2024–2030.

Composition, supplied form and processing history determine the usable material. Evaluate the property required by the actual application with the specified test method; a chemistry name alone does not define a finished grade.

What turns activity into demand

Qualified formulation or component output creates material purchases through loading, process yield and the supplied mass basis. Raw material, formulated blend and finished-part revenues describe separate transaction stages.

The commercial boundary

For Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2), distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable diamantane (cas 2292-79-7) and adamantane (cas 281-23-2) performance?

Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units. Match formulation and impurity limits to the converting process, then verify the property after processing or curing. Compare like-for-like dry or as-supplied quantities; a finished component and its raw material represent different transaction stages.

Selected research

Industry Growth & Trends

Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Growth and Trends Forecast to 2032

21 December 2025123 pages

Choose your research edition.

Industry ResearchDiamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units. The lattice is an all-sp³, rigid three-dimensional network whose local connectivity echoes that of diamond, conferring exceptional chemical inertness, thermal robustness, and pronounced hydrophobicity. In structural hierarchy, diamantane is the higher homologue of adamantane, preserving the same symmetry logic while increasing framework complexity.

Adamantane (C₁₀H₁₆) is a colorless crystalline solid with a camphor-like odor and is the prototypical diamondoid. Its defining feature is a strain-free, highly symmetrical tricyclic cage of saturated, tetrahedral carbons that restricts internal bond rotation relative to ordinary acyclic or monocyclic hydrocarbons. Adamantane occurs naturally in certain crude oils and is also readily accessible synthetically, making it a durable scaffold for structure–property studies and a useful building block in materials and molecular design.

Synthetically, adamantane can be produced via the thermal, catalyst-assisted rearrangement of dicyclopentadiene (C₁₀H₁₆ → C₁₀H₁₆, Δ, catalyst), a classic cage-forming transformation that delivers a low-strain, high-symmetry framework from readily available feedstock. This blueprint underpins routes to higher diamondoids such as diamantane by extending the logic of cage construction from simpler polycyclic precursors.

Read the full market overview

According to APO Research’s survey and statistical analysis, the global diamantane market was valued at US$442.21 thousand in 2023 and is projected to reach US$697.62 thousand by 2030, implying a 2024–2030 CAGR of 6.83%. The global adamantane market was valued at US$184.47 million in 2023 and is expected to reach US$262.53 million by 2030 (CAGR 4.97%). By production value, North America’s adamantane market rises from US$51.84 million (2023) to US$72.62 million (2030; 4.75%), while diamantane increases from US$217.62 thousand to US$354.61 thousand (7.49%). Europe’s adamantane advances from US$28.91 million to US$39.80 million (4.44%) and diamantane from US$51.38 thousand to US$76.60 thousand (5.27%). China’s adamantane expands from US$44.45 million to US$71.04 million (6.66%) and diamantane from US$70.22 thousand to US$114.88 thousand (7.51%). Japan’s adamantane grows from US$40.73 million to US$55.47 million (4.28%) and diamantane from US$99.85 thousand to US$147.20 thousand (5.79%). Overall, adamantane retains the larger revenue base with steady growth, while diamantane—though smaller in absolute terms—exhibits a faster compound growth trajectory over 2024–2030.

The global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

The Asia Pacific market for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) include TCI America, City Chemical, Combi Blocks, Santa Cruz Biotechnology, abcr GmbH, BOC Sciences, Aceschem Inc, A2B Chem and Amadis Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market size, estimates, and forecasts are presented in terms of sales volume (g) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Company

TCI America

City Chemical

Combi Blocks

Santa Cruz Biotechnology

abcr GmbH

BOC Sciences

Aceschem Inc

A2B Chem

Amadis Chemical

Chiralen Pharmaceutical

Starshine Chemical

Ambinter (Greenpharma)

AstaTech

Shanghai Maikelin Biochemical Technology

Aladdin

Chiron

Sigma-Aldrich

Thermo Scientific

Matrix Scientific

AbMole Bioscience

Smolecule

Biosynth

Alfa Chemistry

ChemScence

Fujifilm

Sichuan Zhongbang New Materials

Minxiang Pharmaceutical

Meryer (Shanghai) Chemical Technology

J&K Scientific

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Segment by Type

Purity: ≥98.0% (GC)

Purity: ＜98.0% (GC)

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Segment by Application

Chemical Reagent

Fine Chemicals

Pharmaceutical Intermediate

Material Intermediate

Medical

Scientific Research

Medical

Scientific Research

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity: ≥98.0% (GC) Table 2. Major Company of Purity: ＜98.0% (GC) Table 3. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 5. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Type (2021-2026) Table 8. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2021-2026) & (USD/g) Table 9. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2027-2032) & (g) Table 10. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Type (2027-2032) Table 13. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2027-2032) & (USD/g) Table 14. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 15. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 17. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 19. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 21. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 23. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (US$ Million) Table 24. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Trends Table 25. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Drivers Table 26. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Opportunities and Challenges Table 27. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Restraints Table 28. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Company (2021-2026) Table 30. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Company (2021-2026) & (g) Table 31. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Share by Company (2021-2026) Table 32. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Price by Company (2021-2026) & (USD/g) Table 33. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Major Company Production Sites and Headquarters Table 35. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Company, Product Type & Application Table 36. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region (2021-2026) & (g) Table 41. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Region (2021-2026) Table 44. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 45. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region (2027-2032) & (g) Table 46. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Region (2027-2032) Table 49. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Value (US$ Million), Price (USD/g) and Gross Margin (2027-2032) Table 50. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 52. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Application (2021-2026) Table 55. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2021-2026) & (USD/g) Table 56. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2027-2032) & (g) Table 57. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Application (2027-2032) Table 60. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2027-2032) & (USD/g) Table 61. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 62. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 64. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 66. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 68. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 70. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (US$ Million) Table 71. TCI America Company Information Table 72. TCI America Business Overview Table 73. TCI America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 74. TCI America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 75. TCI America Recent Development Table 76. City Chemical Company Information Table 77. City Chemical Business Overview Table 78. City Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 79. City Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 80. City Chemical Recent Development Table 81. Combi Blocks Company Information Table 82. Combi Blocks Business Overview Table 83. Combi Blocks Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 84. Combi Blocks Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 85. Combi Blocks Recent Development Table 86. Santa Cruz Biotechnology Company Information Table 87. Santa Cruz Biotechnology Business Overview Table 88. Santa Cruz Biotechnology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 89. Santa Cruz Biotechnology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 90. Santa Cruz Biotechnology Recent Development Table 91. abcr GmbH Company Information Table 92. abcr GmbH Business Overview Table 93. abcr GmbH Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 94. abcr GmbH Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 95. abcr GmbH Recent Development Table 96. BOC Sciences Company Information Table 97. BOC Sciences Business Overview Table 98. BOC Sciences Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 99. BOC Sciences Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 100. BOC Sciences Recent Development Table 101. Aceschem Inc Company Information Table 102. Aceschem Inc Business Overview Table 103. Aceschem Inc Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 104. Aceschem Inc Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 105. Aceschem Inc Recent Development Table 106. A2B Chem Company Information Table 107. A2B Chem Business Overview Table 108. A2B Chem Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 109. A2B Chem Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 110. A2B Chem Recent Development Table 111. Amadis Chemical Company Information Table 112. Amadis Chemical Business Overview Table 113. Amadis Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 114. Amadis Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 115. Amadis Chemical Recent Development Table 116. Chiralen Pharmaceutical Company Information Table 117. Chiralen Pharmaceutical Business Overview Table 118. Chiralen Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 119. Chiralen Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 120. Chiralen Pharmaceutical Recent Development Table 121. Starshine Chemical Company Information Table 122. Starshine Chemical Business Overview Table 123. Starshine Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 124. Starshine Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 125. Starshine Chemical Recent Development Table 126. Ambinter (Greenpharma) Company Information Table 127. Ambinter (Greenpharma) Business Overview Table 128. Ambinter (Greenpharma) Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 129. Ambinter (Greenpharma) Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 130. Ambinter (Greenpharma) Recent Development Table 131. AstaTech Company Information Table 132. AstaTech Business Overview Table 133. AstaTech Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 134. AstaTech Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 135. AstaTech Recent Development Table 136. Shanghai Maikelin Biochemical Technology Company Information Table 137. Shanghai Maikelin Biochemical Technology Business Overview Table 138. Shanghai Maikelin Biochemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 139. Shanghai Maikelin Biochemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 140. Shanghai Maikelin Biochemical Technology Recent Development Table 141. Aladdin Company Information Table 142. Aladdin Business Overview Table 143. Aladdin Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 144. Aladdin Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 145. Aladdin Recent Development Table 146. Chiron Company Information Table 147. Chiron Business Overview Table 148. Chiron Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 149. Chiron Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 150. Chiron Recent Development Table 151. Sigma-Aldrich Company Information Table 152. Sigma-Aldrich Business Overview Table 153. Sigma-Aldrich Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 154. Sigma-Aldrich Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 155. Sigma-Aldrich Recent Development Table 156. Thermo Scientific Company Information Table 157. Thermo Scientific Business Overview Table 158. Thermo Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 159. Thermo Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 160. Thermo Scientific Recent Development Table 161. Matrix Scientific Company Information Table 162. Matrix Scientific Business Overview Table 163. Matrix Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 164. Matrix Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 165. Matrix Scientific Recent Development Table 166. AbMole Bioscience Company Information Table 167. AbMole Bioscience Business Overview Table 168. AbMole Bioscience Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 169. AbMole Bioscience Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 170. AbMole Bioscience Recent Development Table 171. Smolecule Company Information Table 172. Smolecule Business Overview Table 173. Smolecule Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 174. Smolecule Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 175. Smolecule Recent Development Table 176. Biosynth Company Information Table 177. Biosynth Business Overview Table 178. Biosynth Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 179. Biosynth Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 180. Biosynth Recent Development Table 181. Alfa Chemistry Company Information Table 182. Alfa Chemistry Business Overview Table 183. Alfa Chemistry Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 184. Alfa Chemistry Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 185. Alfa Chemistry Recent Development Table 186. ChemScence Company Information Table 187. ChemScence Business Overview Table 188. ChemScence Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 189. ChemScence Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 190. ChemScence Recent Development Table 191. Fujifilm Company Information Table 192. Fujifilm Business Overview Table 193. Fujifilm Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 194. Fujifilm Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 195. Fujifilm Recent Development Table 196. Sichuan Zhongbang New Materials Company Information Table 197. Sichuan Zhongbang New Materials Business Overview Table 198. Sichuan Zhongbang New Materials Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 199. Sichuan Zhongbang New Materials Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 200. Sichuan Zhongbang New Materials Recent Development Table 201. Minxiang Pharmaceutical Company Information Table 202. Minxiang Pharmaceutical Business Overview Table 203. Minxiang Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 204. Minxiang Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 205. Minxiang Pharmaceutical Recent Development Table 206. Meryer (Shanghai) Chemical Technology Company Information Table 207. Meryer (Shanghai) Chemical Technology Business Overview Table 208. Meryer (Shanghai) Chemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 209. Meryer (Shanghai) Chemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 210. Meryer (Shanghai) Chemical Technology Recent Development Table 211. J&K Scientific Company Information Table 212. J&K Scientific Business Overview Table 213. J&K Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 214. J&K Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 215. J&K Scientific Recent Development Table 216. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 217. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 218. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Country (2021-2026) Table 219. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032) & (g) Table 220. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share Forecast by Country (2027-2032) Table 221. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026) & (US$ Million) Table 223. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share by Country (2021-2026) Table 224. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share Forecast by Country (2027-2032) Table 226. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 227. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 228. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Country (2021-2026) Table 229. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032) & (g) Table 230. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share Forecast by Country (2027-2032) Table 231. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 232. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026) & (US$ Million) Table 233. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share by Country (2021-2026) Table 234. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 235. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share Forecast by Country (2027-2032) Table 236. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 237. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 238. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Country (2021-2026) Table 239. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032) & (g) Table 240. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share Forecast by Country (2027-2032) Table 241. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 242. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026) & (US$ Million) Table 243. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share by Country (2021-2026) Table 244. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 245. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share Forecast by Country (2027-2032) Table 246. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 247. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 248. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Country (2021-2026) Table 249. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032) & (g) Table 250. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share Forecast by Country (2027-2032) Table 251. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 252. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026) & (US$ Million) Table 253. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share by Country (2021-2026) Table 254. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 255. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share Forecast by Country (2027-2032) Table 256. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 257. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 258. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Country (2021-2026) Table 259. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032) & (g) Table 260. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share Forecast by Country (2027-2032) Table 261. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 262. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026) & (US$ Million) Table 263. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share by Country (2021-2026) Table 264. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 265. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share Forecast by Country (2027-2032) Table 266. Key Raw Materials Table 267. Raw Materials Key Suppliers Table 268. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Distributors List Table 269. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Customers List Table 270. Research Programs/Design for This Report Table 271. Authors List of This Report Table 272. Secondary Sources Table 273. Primary Sources List of Figures Figure 1. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Image Figure 2. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size (2021-2032) & (US$ Million) Figure 4. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (2021-2032) & (g) Figure 5. Purity: ≥98.0% (GC) Image Figure 6. Global Purity: ≥98.0% (GC) Sales YoY Growth (2021-2032) & (g) Figure 7. Purity: ＜98.0% (GC) Image Figure 8. Global Purity: ＜98.0% (GC) Sales YoY Growth (2021-2032) & (g) Figure 9. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share by Type 2025 VS 2032 Figure 11. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Type in 2025 Figure 12. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Type in 2025 Figure 13. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Chemical Reagent Image Figure 24. Global Chemical Reagent Sales YoY Growth (2021-2032) & (g) Figure 25. Fine Chemicals Image Figure 26. Global Fine Chemicals Sales YoY Growth (2021-2032) & (g) Figure 27. Pharmaceutical Intermediate Image Figure 28. Global Pharmaceutical Intermediate Sales YoY Growth (2021-2032) & (g) Figure 29. Material Intermediate Image Figure 30. Global Material Intermediate Sales YoY Growth (2021-2032) & (g) Figure 31. Medical Image Figure 32. Global Medical Sales YoY Growth (2021-2032) & (g) Figure 33. Scientific Research Image Figure 34. Global Scientific Research Sales YoY Growth (2021-2032) & (g) Figure 35. Medical Image Figure 36. Global Medical Sales YoY Growth (2021-2032) & (g) Figure 37. Scientific Research Image Figure 38. Global Scientific Research Sales YoY Growth (2021-2032) & (g) Figure 39. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Share by Application 2025 VS 2032 Figure 41. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Application in 2025 Figure 42. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Application in 2025 Figure 43. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Application in 2025 Figure 44. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share in Value by Application in 2025 Figure 47. L

Scope & coverage.

Types
  • Purity: ≥98.0% (GC)
  • Purity: ＜98.0% (GC)
Applications
  • Chemical Reagent
  • Fine Chemicals
  • Pharmaceutical Intermediate
  • Material Intermediate
  • Medical
  • Scientific Research
  • Medical
  • Scientific Research
Companies covered
  • TCI America
  • City Chemical
  • Combi Blocks
  • Santa Cruz Biotechnology
  • abcr GmbH
  • BOC Sciences
  • Aceschem Inc
  • A2B Chem
  • Amadis Chemical
  • Chiralen Pharmaceutical
  • Starshine Chemical
  • Ambinter (Greenpharma)
  • AstaTech
  • Shanghai Maikelin Biochemical Technology
  • Aladdin
  • Chiron
  • Sigma-Aldrich
  • Thermo Scientific
  • Matrix Scientific
  • AbMole Bioscience
  • Smolecule
  • Biosynth
  • Alfa Chemistry
  • ChemScence
  • Fujifilm
  • Sichuan Zhongbang New Materials
  • Minxiang Pharmaceutical
  • Meryer (Shanghai) Chemical Technology
  • J&K Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Type
  6. 1.3.1 Purity: ≥98.0% (GC)
  7. 1.3.2 Purity: ＜98.0% (GC)
  8. 1.4 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Type
  9. 1.4.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Trends
  2. 2.2 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Drivers
  3. 2.3 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Opportunities and Challenges
  4. 2.4 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2026)
  2. 3.2 Global Top Players by Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (2021-2026)
  3. 3.3 Global Top Players by Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price (2021-2026)
  4. 3.4 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Major Company Production Sites & Headquarters
  6. 3.6 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Company, Product Type & Application
  7. 3.7 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Tier 1, Tier 2, and Tier 3
4 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Regional Status and Outlook
  1. 4.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Historic Market Size by Region
  3. 4.2.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Forecasted Market Size by Region
  7. 4.3.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) by Application
  1. 5.1 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Application
  2. 5.1.1 Chemical Reagent
  3. 5.1.2 Fine Chemicals
  4. 5.1.3 Pharmaceutical Intermediate
  5. 5.1.4 Material Intermediate
  6. 5.1.5 Medical
  7. 5.1.6 Scientific Research
  8. 5.1.7 Medical
  9. 5.1.8 Scientific Research
  10. 5.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Application
  11. 5.2.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Overview by Application (2021-2032)
  12. 5.2.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Historic Market Size Review by Application (2021-2026)
  13. 5.2.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Forecasted Market Size by Application (2027-2032)
  14. 5.3 Key Regions Market Size by Application
  15. 5.3.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Application (2021-2026)
  16. 5.3.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Application (2021-2026)
  17. 5.3.3 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Application (2021-2026)
  18. 5.3.4 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Application (2021-2026)
  19. 5.3.5 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 TCI America
  2. 6.1.1 TCI America Company Information
  3. 6.1.2 TCI America Business Overview
  4. 6.1.3 TCI America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 TCI America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  6. 6.1.5 TCI America Recent Developments
  7. 6.2 City Chemical
  8. 6.2.1 City Chemical Company Information
  9. 6.2.2 City Chemical Business Overview
  10. 6.2.3 City Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 City Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  12. 6.2.5 City Chemical Recent Developments
  13. 6.3 Combi Blocks
  14. 6.3.1 Combi Blocks Company Information
  15. 6.3.2 Combi Blocks Business Overview
  16. 6.3.3 Combi Blocks Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Combi Blocks Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  18. 6.3.5 Combi Blocks Recent Developments
  19. 6.4 Santa Cruz Biotechnology
  20. 6.4.1 Santa Cruz Biotechnology Company Information
  21. 6.4.2 Santa Cruz Biotechnology Business Overview
  22. 6.4.3 Santa Cruz Biotechnology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Santa Cruz Biotechnology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  24. 6.4.5 Santa Cruz Biotechnology Recent Developments
  25. 6.5 abcr GmbH
  26. 6.5.1 abcr GmbH Company Information
  27. 6.5.2 abcr GmbH Business Overview
  28. 6.5.3 abcr GmbH Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 abcr GmbH Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  30. 6.5.5 abcr GmbH Recent Developments
  31. 6.6 BOC Sciences
  32. 6.6.1 BOC Sciences Company Information
  33. 6.6.2 BOC Sciences Business Overview
  34. 6.6.3 BOC Sciences Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BOC Sciences Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  36. 6.6.5 BOC Sciences Recent Developments
  37. 6.7 Aceschem Inc
  38. 6.7.1 Aceschem Inc Company Information
  39. 6.7.2 Aceschem Inc Business Overview
  40. 6.7.3 Aceschem Inc Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aceschem Inc Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  42. 6.7.5 Aceschem Inc Recent Developments
  43. 6.8 A2B Chem
  44. 6.8.1 A2B Chem Company Information
  45. 6.8.2 A2B Chem Business Overview
  46. 6.8.3 A2B Chem Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 A2B Chem Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  48. 6.8.5 A2B Chem Recent Developments
  49. 6.9 Amadis Chemical
  50. 6.9.1 Amadis Chemical Company Information
  51. 6.9.2 Amadis Chemical Business Overview
  52. 6.9.3 Amadis Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Amadis Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  54. 6.9.5 Amadis Chemical Recent Developments
  55. 6.10 Chiralen Pharmaceutical
  56. 6.10.1 Chiralen Pharmaceutical Company Information
  57. 6.10.2 Chiralen Pharmaceutical Business Overview
  58. 6.10.3 Chiralen Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chiralen Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  60. 6.10.5 Chiralen Pharmaceutical Recent Developments
  61. 6.11 Starshine Chemical
  62. 6.11.1 Starshine Chemical Company Information
  63. 6.11.2 Starshine Chemical Business Overview
  64. 6.11.3 Starshine Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Starshine Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  66. 6.11.5 Starshine Chemical Recent Developments
  67. 6.12 Ambinter (Greenpharma)
  68. 6.12.1 Ambinter (Greenpharma) Company Information
  69. 6.12.2 Ambinter (Greenpharma) Business Overview
  70. 6.12.3 Ambinter (Greenpharma) Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ambinter (Greenpharma) Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  72. 6.12.5 Ambinter (Greenpharma) Recent Developments
  73. 6.13 AstaTech
  74. 6.13.1 AstaTech Company Information
  75. 6.13.2 AstaTech Business Overview
  76. 6.13.3 AstaTech Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AstaTech Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  78. 6.13.5 AstaTech Recent Developments
  79. 6.14 Shanghai Maikelin Biochemical Technology
  80. 6.14.1 Shanghai Maikelin Biochemical Technology Company Information
  81. 6.14.2 Shanghai Maikelin Biochemical Technology Business Overview
  82. 6.14.3 Shanghai Maikelin Biochemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Shanghai Maikelin Biochemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  84. 6.14.5 Shanghai Maikelin Biochemical Technology Recent Developments
  85. 6.15 Aladdin
  86. 6.15.1 Aladdin Company Information
  87. 6.15.2 Aladdin Business Overview
  88. 6.15.3 Aladdin Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Aladdin Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  90. 6.15.5 Aladdin Recent Developments
  91. 6.16 Chiron
  92. 6.16.1 Chiron Company Information
  93. 6.16.2 Chiron Business Overview
  94. 6.16.3 Chiron Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Chiron Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  96. 6.16.5 Chiron Recent Developments
  97. 6.17 Sigma-Aldrich
  98. 6.17.1 Sigma-Aldrich Company Information
  99. 6.17.2 Sigma-Aldrich Business Overview
  100. 6.17.3 Sigma-Aldrich Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Sigma-Aldrich Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  102. 6.17.5 Sigma-Aldrich Recent Developments
  103. 6.18 Thermo Scientific
  104. 6.18.1 Thermo Scientific Company Information
  105. 6.18.2 Thermo Scientific Business Overview
  106. 6.18.3 Thermo Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Thermo Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  108. 6.18.5 Thermo Scientific Recent Developments
  109. 6.19 Matrix Scientific
  110. 6.19.1 Matrix Scientific Company Information
  111. 6.19.2 Matrix Scientific Business Overview
  112. 6.19.3 Matrix Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Matrix Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  114. 6.19.5 Matrix Scientific Recent Developments
  115. 6.20 AbMole Bioscience
  116. 6.20.1 AbMole Bioscience Company Information
  117. 6.20.2 AbMole Bioscience Business Overview
  118. 6.20.3 AbMole Bioscience Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 AbMole Bioscience Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  120. 6.20.5 AbMole Bioscience Recent Developments
  121. 6.21 Smolecule
  122. 6.21.1 Smolecule Company Information
  123. 6.21.2 Smolecule Business Overview
  124. 6.21.3 Smolecule Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Smolecule Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  126. 6.21.5 Smolecule Recent Developments
  127. 6.22 Biosynth
  128. 6.22.1 Biosynth Company Information
  129. 6.22.2 Biosynth Business Overview
  130. 6.22.3 Biosynth Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Biosynth Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  132. 6.22.5 Biosynth Recent Developments
  133. 6.23 Alfa Chemistry
  134. 6.23.1 Alfa Chemistry Company Information
  135. 6.23.2 Alfa Chemistry Business Overview
  136. 6.23.3 Alfa Chemistry Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Alfa Chemistry Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  138. 6.23.5 Alfa Chemistry Recent Developments
  139. 6.24 ChemScence
  140. 6.24.1 ChemScence Company Information
  141. 6.24.2 ChemScence Business Overview
  142. 6.24.3 ChemScence Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 ChemScence Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  144. 6.24.5 ChemScence Recent Developments
  145. 6.25 Fujifilm
  146. 6.25.1 Fujifilm Company Information
  147. 6.25.2 Fujifilm Business Overview
  148. 6.25.3 Fujifilm Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Fujifilm Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  150. 6.25.5 Fujifilm Recent Developments
  151. 6.26 Sichuan Zhongbang New Materials
  152. 6.26.1 Sichuan Zhongbang New Materials Company Information
  153. 6.26.2 Sichuan Zhongbang New Materials Business Overview
  154. 6.26.3 Sichuan Zhongbang New Materials Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Sichuan Zhongbang New Materials Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  156. 6.26.5 Sichuan Zhongbang New Materials Recent Developments
  157. 6.27 Minxiang Pharmaceutical
  158. 6.27.1 Minxiang Pharmaceutical Company Information
  159. 6.27.2 Minxiang Pharmaceutical Business Overview
  160. 6.27.3 Minxiang Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Minxiang Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  162. 6.27.5 Minxiang Pharmaceutical Recent Developments
  163. 6.28 Meryer (Shanghai) Chemical Technology
  164. 6.28.1 Meryer (Shanghai) Chemical Technology Company Information
  165. 6.28.2 Meryer (Shanghai) Chemical Technology Business Overview
  166. 6.28.3 Meryer (Shanghai) Chemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  167. 6.28.4 Meryer (Shanghai) Chemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  168. 6.28.5 Meryer (Shanghai) Chemical Technology Recent Developments
  169. 6.29 J&K Scientific
  170. 6.29.1 J&K Scientific Company Information
  171. 6.29.2 J&K Scientific Business Overview
  172. 6.29.3 J&K Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue and Gross Margin (2021-2026)
  173. 6.29.4 J&K Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  174. 6.29.5 J&K Scientific Recent Developments
7 North America by Country
  1. 7.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country
  2. 7.1.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026)
  4. 7.1.3 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  6. 7.2.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026)
  8. 7.2.3 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country
  2. 8.1.1 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026)
  4. 8.1.3 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  6. 8.2.1 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country
  2. 9.1.1 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  6. 9.2.1 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country
  2. 10.1.1 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026)
  4. 10.1.3 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  6. 10.2.1 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026)
  8. 10.2.3 South America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country
  2. 11.1.1 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  6. 11.2.1 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Value Chain Analysis
  2. 12.1.1 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production Mode & Process
  7. 12.2 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Distributors
  10. 12.2.3 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst